Notice Concerning Initiation Of Pediatric Phase III Clinical Trial Of KD-414, An Inactivated COVID-19 Vaccine
31/01/2023 06:05
Jan 31 (Reuters) - Meiji Holdings Co Ltd 2269.T :
* NOTICE CONCERNING INITIATION OF PEDIATRIC PHASE III
CLINICAL
TRIAL OF KD-414, AN INACTIVATED COVID-19 VACCINE
Source text for Eikon: ID:nTSme91ae4
Further company coverage: 2269.T